Chief Healthcare Executive February 22, 2021
The total cost is approximately $39 per enrolled patient compared to $239 per patient for a traditional cohort study.
A virtually enabled biorepository and electronic health record (EHR)-embedded, scalable cohort for precision medicine (VESPRE) demonstrated feasible digital screening, successful enrollment, biologic sampling, and lower costs compared with a traditional study design.
Study findings indicated VESPRE may be scalable across patients, centers, and laboratories at low incremental cost and burden.
Kimberley DeMerle, M.D., and a team of investigators developed VESPRE and compared the feasibility, enrollment, and costs compared with those of a traditional study design in acute care. The goals of VESPRE were to create a digital tool for patient screening and enrollment embedded in the EHR, to develop automated sample...
Today's Sponsors
Today's Sponsor